Elite Pharmaceuticals Inc (ELTP)
0.1543
0.00 (0.00%)
USD |
OTCM |
Mar 28, 16:00
Elite Pharmaceuticals Cash from Investing (TTM): -0.9422M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.9422M |
September 30, 2023 | -0.5369M |
June 30, 2023 | -5.642M |
March 31, 2023 | -5.737M |
December 31, 2022 | -5.465M |
September 30, 2022 | -5.546M |
June 30, 2022 | -0.5882M |
March 31, 2022 | -0.4986M |
December 31, 2021 | -0.4193M |
September 30, 2021 | -0.3749M |
June 30, 2021 | -0.305M |
March 31, 2021 | -0.2628M |
December 31, 2020 | -0.1097M |
September 30, 2020 | -0.072M |
June 30, 2020 | 0.0053M |
March 31, 2020 | -0.035M |
December 31, 2019 | 0.3469M |
September 30, 2019 | 0.3277M |
June 30, 2019 | 0.5065M |
March 31, 2019 | 0.3309M |
December 31, 2018 | 0.0827M |
September 30, 2018 | 0.187M |
June 30, 2018 | -0.1176M |
March 31, 2018 | -0.2748M |
December 31, 2017 | -0.6696M |
Date | Value |
---|---|
September 30, 2017 | -1.047M |
June 30, 2017 | -1.156M |
March 31, 2017 | -1.105M |
December 31, 2016 | -1.383M |
September 30, 2016 | -1.045M |
June 30, 2016 | -1.517M |
March 31, 2016 | -1.949M |
December 31, 2015 | -1.977M |
September 30, 2015 | -2.407M |
June 30, 2015 | -2.077M |
March 31, 2015 | 2.879M |
December 31, 2014 | 3.414M |
September 30, 2014 | 3.481M |
June 30, 2014 | 3.817M |
March 31, 2014 | -0.5577M |
December 31, 2013 | -0.4391M |
September 30, 2013 | -0.2352M |
June 30, 2013 | -0.2548M |
March 31, 2013 | -0.1918M |
December 31, 2012 | -0.3603M |
September 30, 2012 | -0.4156M |
June 30, 2012 | -0.4278M |
March 31, 2012 | -0.6578M |
December 31, 2011 | -1.473M |
September 30, 2011 | -1.444M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.737M
Minimum
Mar 2023
0.5065M
Maximum
Jun 2019
-1.251M
Average
-0.3399M
Median
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.017M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Ampio Pharmaceuticals Inc | -- |